Samsung Bioepis Presents Post-hoc Analysis of Phase 3
Switching study conducted to evaluate whether switching from reference aflibercept to SB15 maintains comparable clinical efficacy and safetyPost-hoc...
Source: globenewswire.com
Stay updated with breaking news from Free Paper Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Switching study conducted to evaluate whether switching from reference aflibercept to SB15 maintains comparable clinical efficacy and safetyPost-hoc...
/PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection...
Abstracts demonstrate efficacy of combination antibiotics with STIMULAN beads compared to a bead with a single antibiotic Martin Rohr joins Biocomposites as the new Sales Manager for Northern